Choice of arterial access site and outcomes in patients with acute coronary syndromes managed with an early invasive strategy: the ACUITY trialHAMON, Martial; RASMUSSEN, Lars H; STONE, Gregg W et al.EuroIntervention. 2009, Vol 5, Num 1, pp 115-120, issn 1774-024X, 6 p.Article

Dietary intake of total marine n-3 polyunsaturated fatty acids, eicosapentaenoic acid, docosahexaenoic acid and docosapentaenoic acid and the risk of acute coronary syndrome - a cohort studyJOENSEN, Albert M; SCHMIDT, Erik B; DETHLEFSEN, Claus et al.British journal of nutrition. 2010, Vol 103, Num 4, pp 602-607, issn 0007-1145, 6 p.Article

Cost Effectiveness of Treatments for Stroke Prevention in Atrial Fibrillation: Focus on the Novel Oral AnticoagulantsKASMERIDIS, Charalampos; APOSTOLAKIS, Stavros; EHLERS, Lars et al.PharmacoEconomics (Auckland). 2013, Vol 31, Num 11, pp 971-980, issn 1170-7690, 10 p.Article

Safety and tolerability of an immediate-release formulation of the oral direct thrombin inhibitor AZD0837 in the prevention of stroke and systemic embolism in patients with atrial fibrillationOISSON, S. Bertil; RASMUSSEN, Lars H; TVEIT, Arnljot et al.Thrombosis and haemostasis. 2010, Vol 103, Num 3, pp 604-612, issn 0340-6245, 9 p.Article

Thromboembolism and antithrombotic therapy for heart failure in sinus rhythm: An Executive Summary of a joint Consensus Document from the ESC Heart Failure Association and the ESC Working Group on ThrombosisLIP, Gregory Y. H; PONIKOWSKI, Piotr; LANE, DeirdreA et al.Thrombosis and haemostasis. 2012, Vol 108, Num 6, pp 1009-1022, issn 0340-6245, 14 p.Article

Oral direct thrombin inhibitor AZD0837 for the prevention of stroke and systemic embolism in patients with non-valvular atriat fibrillation: a randomized dose-guiding, safety, and tolerability study of four doses of AZD0837 vs. vitamin K antagonistsLIP, Gregory Y. H; RASMUSSEN, Lars H; BERTIL OLSSON, S et al.European heart journal. 2009, Vol 30, Num 23, pp 2897-2907, issn 0195-668X, 11 p.Article

Randomized trial comparing endovenous laser ablation of the great saphenous vein with high ligation and stripping in patients with varicose veins : Short-term resultsRASMUSSEN, Lars H; BJOERN, Lars; LAWAETZ, Martin et al.Journal of vascular surgery. 2007, Vol 46, Num 2, pp 308-315, issn 0741-5214, 8 p.Conference Paper

Oral direct thrombin inhibitor AZD0837 for the prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation: A Phase II study of AZD0837 in patients who are appropriate for but unable or unwilling to take vitamin K antagonist therapyLIP, Gregory Y. H; RASMUSSEN, Lars H; OLSSON, S. Bertil et al.Thrombosis research. 2011, Vol 127, Num 2, pp 91-99, issn 0049-3848, 9 p.Article

Microbial degradation and impact of bracken toxin ptaquiloside on microbial communities in soilENGEL, Pernille; BRANDT, Kristian K; RASMUSSEN, Lars H et al.Chemosphere (Oxford). 2007, Vol 67, Num 1, pp 202-209, issn 0045-6535, 8 p.Article

Bivalirudin for patients with acute coronary syndromesSTONE, Gregg W; MCLAURIN, Brent T; COLOMBO, Antonio et al.The New England journal of medicine. 2006, Vol 355, Num 21, pp 2203-2216, issn 0028-4793, 14 p.Article

Kinetics of ptaquiloside hydrolysis in aqueous solutionAYALA-LUIS, Karina B; HANSEN, Pernille B; RASMUSSEN, Lars H et al.Environmental toxicology and chemistry. 2006, Vol 25, Num 10, pp 2623-2629, issn 0730-7268, 7 p.Article